Picture of Centogene NV logo

CNTG Centogene NV Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Annual cashflow statement for Centogene NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUS20-F20-F20-F20-F
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-11.6-20.7-21.1-46.9-38.6
Depreciation
Non-Cash Items5.67.249.8810.97.97
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital-3.7-0.94.56-7.09-6.24
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-4.58-7.788.46-21.7-26.5
Capital Expenditures-11.8-7.58-16.5-5.7-2.09
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items3.0821.80.3960.3421.36
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities-8.6914.2-16.2-5.36-0.733
Financing Cash Flow Items1939.9-0.248-0.267-4.91
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities19.325.514.8-3.246.3
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash6.0731.97.06-30.318.1